forbes best glp 1 companies World's Top 20 AI Drug Development Dynamic GLP The Biggest Winner of GLP-1

Poor nutrition and obesity disproportionately affect individuals with lower socioeconomic status in rural communities and in racial and ethnic minoritized populations, 234 and disparities in poor nutrition and obesity prevalence are mirrored in disparities in access to quality health care

Bittner B, McIntyre C, Tian H, Tang K, Shah N, Phuapradit W, et al

Human An earlier review on pharmacotherapy for gestational diabetes reported no human data on the safety of GLP-1 agonists during pregnancy and concluded that these drugs cannot be recommended in pregnancy (30)

[7] [27] A thorough assessment should include screening for contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Nutritional solutions are increasingly required to mitigate side effects such as muscle loss, which affects over 40% of GLP-1 users